<DOC>
	<DOCNO>NCT02800551</DOCNO>
	<brief_summary>This study compare pain ( primary end-point ) local metastatic tumor control ( secondary end-point ) dose-intensified image-guided fractionate stereotactic body radiation therapy ( SBRT ) painful mass-type spinal metastasis versus conventional radiation therapy .</brief_summary>
	<brief_title>Clinical Trial Comparing Dose-intensified SBRT With Conventional Radiation Therapy Spinal Metastases</brief_title>
	<detailed_description>Rationale : Radiation therapy effective palliative treatment painful spinal metastasis . A sub-group patient mass-type spinal metastasis , factor associate poor local metastasis control , require treatment optimization ensure durable pain control metastatic tumor control . Proposed solution : To intensify ( escalate ) radiation dose use simultaneous integrate boost image-guided hypofractionated SBRT painful mass-type spinal metastasis randomize controlled trial . Two experimental fractionation regime test study depend presence absence epidural involvement . Dose intensification expect achieve long-term pain control long-term palliation well long-term local metastatic tumor control without add toxicity compare conventional fractionation regimes conventional radiation therapy . The study carry multinational , multicentre phase II clinical control trial enrolling patient painful mass-type spinal metastasis eligible radiation therapy without surgery .</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<criteria>Established histological diagnosis malignant primary metastatic tumor ; Histologically , radiologically scintigraphically proven spinal metastasis ; Pain affect spinal region free pain pain medication ; Age ≥18 year old ; Karnofsky performance status ≥60 % ; Written inform consent . Modified Bauer Score &lt; 2 ; Nomasstype metastatic lesion , define 3D spaceoccupying lesion visible CT and/or MR ; `` Radiosensitive '' histology primary tumor , e.g. , lymphoma , smallcell lung cancer , multiple myeloma , germ cell tumor ; Progressive neurological symptoms/deficit ; More 3 affect vertebra one target site ; More 2 treatment site ; Spinal Instability Neoplastic Score ( SINS ) 13 18 , i.e. , unstable ; Unable tolerate treatment ( unable lie flat immobilize ) ; Previous radiotherapy region level affect vertebra ; Previous radionuclide therapy within 30 day stereotactic body radiation therapy ; Previous surgery ( stabilization ) affect vertebra ; Contraindications MR scanning , e.g. , pacemaker ; Patients allergy contrast agent use computer tomography ( CT ) magnetic resonance ( MR ) image patient premedicated use contrast agent ; Pregnant lactate woman ; Women child bear potential sexually active male willing use effective contraception treatment 3 month end treatment ; Mental condition render patient unable understand nature , scope , possible consequence study ; Patient unlikely comply protocol , i.e . uncooperative attitude , inability return followup visit , unlikely complete study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>